The role of oxidative stress in neurodegenerative diseases and potential antioxidant therapies
Adv Lab Med. 2022 Dec 19;3(4):342-360.
doi: 10.1515/almed-2022-0111.
eCollection 2022 Dec.
[Article in
English,
Spanish]
Authors
Paula Sienes Bailo
1
2
3
, Elena Llorente Martín
3
4
, Pilar Calmarza
1
2
3
5
6
7
, Silvia Montolio Breva
3
8
, Adrián Bravo Gómez
3
4
9
, Adela Pozo Giráldez
3
10
, Joan J Sánchez-Pascuala Callau
3
11
, Juana M Vaquer Santamaría
3
10
, Anita Dayaldasani Khialani
3
12
, Concepción Cerdá Micó
3
13
, Jordi Camps Andreu
3
14
15
16
17
, Guillermo Sáez Tormo
3
18
19
, Isabel Fort Gallifa
3
8
14
16
17
20
Affiliations
- 1 Servicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, Zaragoza, Spain.
- 2 Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
- 3 Sociedad Española de Medicina de Laboratorio (SEQC-ML), Comisión de Estrés Oxidativo, Barcelona, Spain.
- 4 Hospital General Universitario Gregorio Marañón, Madrid, Spain.
- 5 Centro de Investigación en Red en Enfermedades Cardiovasculares (CIBERCV), Quebec, Spain.
- 6 Universidad de Zaragoza, Zaragoza, Spain.
- 7 Comisión de Lipoproteínas y Enfermedades Cardiovasculares, SEQC-ML, Barcelona, Spain.
- 8 Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
- 9 Comisión de Elementos traza, SEQC-ML, Barcelona, Spain.
- 10 Servicio de Bioquímica Clínica y Patología Molecular, Hospital Clínico Universitario de Valencia, Valencia, Spain.
- 11 Hospital Verge de la Cinta, Tortosa, Spain.
- 12 UGD de Laboratorio, Hospital Regional Universitario de Málaga, Málaga, Spain.
- 13 Dirección Médica Asistencial, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
- 14 Universitat Rovira i Virgili, Tarragona, Spain.
- 15 Hospital Universitari Sant Joan de Reus, Tarragona, Spain.
- 16 Institut d'Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.
- 17 Centre Recerca Biomèdica, Tarragona, Spain.
- 18 Unidad de Patología Oxidativa-UPOX-UV, Universidad de Valencia, Valencia, Spain.
- 19 Servicio de Análisis Clínicos, Hospital Universitario Doctor Peset, Valencia, Spain.
- 20 Laboratori ICS de Tarragona i Terres de l'Ebre, Tarragona, Spain.
Abstract
Objectives:
The central nervous system (CNS) is essential for homeostasis and controls the physiological functions of the body. However, the biochemical characteristics of the CNS make it especially vulnerable to oxidative damage (OS). This phenomenon compromises correct CNS functioning, leading to neurodegeneration and neuronal death.
Contents:
OS plays a crucial role in the physiopathology of neurodegenerative diseases. It is involved in multiple mechanisms of nucleic acid, protein, and lipid oxidation, thereby contributing to progressive brain damage. These mechanisms include mitochondrial dysfunction; excessive production of reactive oxygen and nitrogen species; deficiency of antioxidant defenses; protein oligomerization; cytokine production and inflammatory response; blood-brain barrier abnormalities; and proteasome dysfunction. All these dysfunctions are involved in the pathogenesis of neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, Huntington's disease, or amyotrophic lateral sclerosis.
Summary and outlook:
A curative treatment is currently not available. Research is focused on the search for therapies that reduce oxidative damage and delay disease progression. In the recent years, researchers have focused their attention on the effects of antioxidant therapies.
Keywords:
antioxidants; biomarkers; neurodegenerative diseases; oxidative stress; reactive species.
© 2022 the author(s), published by De Gruyter, Berlin/Boston.